Related Experiment Video
Updated: Sep 16, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Published on: February 23, 2024
Cancer Survivorship Care in Bavaria: General Practitioners' Perspectives and a Regional Capacity Analysis
Laura Oestreich1, Jörg Schelling2, Michael Schoenberg3
1LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Department of Medicine III, Germany, Munich.
Background:
The rising number of cancer survivors in Germany increases the need for long-term, coordinated cross-sectoral care. General practitioners (GPs) play a key role, yet evidence on regional structures and GPs' perspectives is limited. This study examines cancer survivorship care in Bavaria by combining a regional capacity analysis with a statewide GP survey.
Methods:
A mixed-methods study was conducted in Bavaria, combining a regional structural analysis of physician availability and projected survivorship care demand with a statewide anonymous quantitative online GP survey on care experiences, collaboration, digital tools, training needs, vaccination practices, and reimbursement.
Results:
In 2024, 9553 Bavarian GPs cared for approximately 380000 cancer survivors, with 17% living in areas of GP undersupply. Northern and Eastern Bavaria showed particularly high patient loads and projected shortages. Among 574 surveyed GPs, 72.7% perceived survivorship care as challenging. Key barriers included insufficient cross-sectoral collaboration (76.9%), limited knowledge of co-treating colleagues' activities (72.6%), incomplete treatment information (31.7%), and inadequate reimbursement (95.2%). While most GPs (71.5%) considered the electronic patient record (ePA) promising, only 56.9% used KIM at least occasionally. 73.1% expressed interest in dedicated training and guidance, particularly regarding vaccination responsibilities and timing (64.1%).
Conclusion:
GPs in Bavaria face increasing structural and organizational challenges due to rising survivor numbers and regional workforce shortages. Improved information exchange, strengthened cross-sectoral collaboration, consistent digital communication, targeted GP training, and continuous regional monitoring, are essential to ensure sustainable, high-quality survivorship care across Germany.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Comparing the Survival Analysis of Two or More Groups
Treatment Resistent Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...